News & Events

Facilitating Price Competition and Innovation in the Biological Products Marketplace Public Hearing

The Food and Drug Administration (FDA or the Agency) is announcing a public hearing on FDA's approach to enhancing competition and innovation in the biological products marketplace, including by facilitating greater availability of biosimilar and interchangeable products.

Date

September 4, 2018

Meeting Location

FDA White Oak Campus
10903 New Hampshire Avenue
Building 31 Conference Center
The Great Room B/C
Silver Spring, MD 20993-0002

The entrance for public meeting participants (non-FDA employees or contractors) is through Building 1, where routine security check procedures will be performed. For parking, security and other visitor information, please refer to Public Meetings at the FDA White Oak Campus.

Background Information

  • Agenda (will be available 5 days prior to the meeting)

If you need special accommodations due to a disability, please contact Allison Hoffman, Ph.D., at 301-796-9203 or OMPTFeedback@fda.hhs.gov no later than Friday, August 17, 2018.

Meeting Information

A recorded webcast and meeting transcript will be posted to this website after the meeting.

Submitting Comments

Regardless of attendance at the public meeting, you can submit electronic or written comments to the public docket by Friday September 21, 2018. Submit electronic comments to Regulations.gov. Submit written comments to the Division of Docket’s Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. Comments received by mail/hand delivery/courier (for written/paper submissions) will be considered timely if they are postmarked or the delivery service acceptance receipt is on or before that date.

All comments must be identified with the docket number FDA-2018-N-2689. The FDA may post, without change, all comments received to Regulations.gov, including any personal information provided.

Questions

If you have questions about registering for the meeting, contact Allison Hoffman, Ph.D., U.S. Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993, phone: 301-796-9203, or email: OMPTFeedback@fda.hhs.gov.

Page Last Updated: 07/24/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English